Enguang Bi

4.2k total citations · 3 hit papers
42 papers, 3.1k citations indexed

About

Enguang Bi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Enguang Bi has authored 42 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 15 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Enguang Bi's work include Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (11 papers). Enguang Bi is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (11 papers). Enguang Bi collaborates with scholars based in China, United States and France. Enguang Bi's co-authors include Jianfei Qian, Qing Yi, Xingzhe Ma, Maojie Yang, Lintao Liu, Qiang Wang, Yong Lu, Lingqun Ye, Liuling Xiao and Su Pan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Enguang Bi

39 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment

2019 697 citations Xingzhe Ma, Enguang Bi et al. Cell Metabolism profile →
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability

2021 664 citations Xingzhe Ma, Liuling Xiao et al. Cell Metabolism profile →
Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages

2020 360 citations Pan Su, Qiang Wang et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Enguang Bi China	20	1.6k	1.2k	1.1k	919	570	42	3.1k
Xingzhe Ma China	19	1.2k 0.7×	1.1k 0.9×	1.1k 1.0×	770 0.8×	556 1.0×	25	2.6k
Lintao Liu China	14	809 0.5×	879 0.7×	925 0.8×	584 0.6×	534 0.9×	29	2.1k
Linda Vatan United States	17	2.4k 1.6×	1.7k 1.4×	818 0.7×	2.3k 2.5×	418 0.7×	25	4.3k
Yong Lu United States	24	1.3k 0.8×	949 0.8×	512 0.5×	1.0k 1.1×	275 0.5×	53	2.6k
Su Yin Lim Australia	28	1.4k 0.9×	1.3k 1.0×	474 0.4×	1.6k 1.8×	415 0.7×	50	3.1k
Michel DuPage United States	13	1.7k 1.1×	1.2k 1.0×	457 0.4×	1.4k 1.5×	345 0.6×	20	3.2k
Linda A. Snyder United States	25	2.7k 1.8×	1.5k 1.2×	614 0.5×	2.4k 2.7×	564 1.0×	46	4.6k
Zheng‐Jun Zhou China	30	1.2k 0.8×	1.6k 1.3×	1.2k 1.1×	1.3k 1.4×	462 0.8×	72	3.6k
Limin Xia China	39	594 0.4×	2.8k 2.3×	1.4k 1.2×	1.0k 1.1×	512 0.9×	142	4.1k
Yuliya Pylayeva‐Gupta United States	18	1.4k 0.9×	1.8k 1.5×	572 0.5×	2.0k 2.2×	255 0.4×	27	3.8k

Countries citing papers authored by Enguang Bi

Since Specialization

Citations

This map shows the geographic impact of Enguang Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enguang Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enguang Bi more than expected).

Fields of papers citing papers by Enguang Bi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enguang Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enguang Bi. The network helps show where Enguang Bi may publish in the future.

Co-authorship network of co-authors of Enguang Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Enguang Bi. A scholar is included among the top collaborators of Enguang Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enguang Bi. Enguang Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yang, Wenli Zhao, Hongyan Liu, et al.. (2025). CXCL13 Expression Promotes CAR T Cell Antitumor Activity and Potentiates Response to PD‐1 Blockade. Advanced Science. 12(33). e08095–e08095. 4 indexed citations

Ren, Jie, et al.. (2024). Discovery of an immunosuppressive functional metabolite from the insect-derived endophytic Aspergillus taichungensis SMU01. Fitoterapia. 176. 106007–106007. 2 indexed citations

Zhao, Wenli, Wei Lin, Yi Xiao, et al.. (2024). Bendamustine–rituximab elicits dual tumoricidal and immunomodulatory responses via cGAS–STING activation in diffuse large B-cell lymphoma. Journal for ImmunoTherapy of Cancer. 12(11). e009212–e009212. 3 indexed citations

Chen, Chunxiao, Zhe Liu, Ning Jiang, et al.. (2023). A phase II study of toripalimab combined with gemcitabine-cisplatin as neoadjuvant therapy for patients with muscle-invasive bladder cancer (MIBC).. Journal of Clinical Oncology. 41(16_suppl). e16602–e16602. 1 indexed citations

Xu, Peng, Chunxiao Chen, Enguang Bi, et al.. (2022). Long-term Follow-up of Detaenial Sigmoid Neobladder Reconstruction for Paediatric Patients with Bladder and Prostate Rhabdomyosarcoma: Technique and Results from a Single High-volume Centre. European Urology. 82(5). 543–550. 1 indexed citations

Wang, Qiang, Zhijuan Lin, Zhuo Wang, et al.. (2021). RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 139(1). 59–72. 16 indexed citations

Yan, Tao, Enguang Bi, Taixue An, et al.. (2021). Hsa_circ_0000652 Aggravates Inflammation by Activation of Macrophages and Enhancement of OX40/OX40L Interaction in Ankylosing Spondylitis. Frontiers in Cell and Developmental Biology. 9. 737599–737599. 11 indexed citations

Su, Pan, Qiang Wang, Enguang Bi, et al.. (2020). Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages. Cancer Research. 80(7). 1438–1450. 360 indexed citations breakdown →

Li, Rong, Chengyun Zheng, Qiang Wang, et al.. (2020). Identification of an immunogenic DKK1 long peptide for immunotherapy of human multiple myeloma. Haematologica. 106(3). 838–846. 5 indexed citations

10.

Ma, Xingzhe, Enguang Bi, Yong Lu, et al.. (2019). Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. Cell Metabolism. 30(1). 143–156.e5. 697 indexed citations breakdown →

11.

Jiang, Yuxue, Jintong Chen, Enguang Bi, et al.. (2019). TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways. Journal for ImmunoTherapy of Cancer. 7(1). 28–28. 48 indexed citations

12.

Ma, Xingzhe, Enguang Bi, Chunjian Huang, et al.. (2018). Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity. The Journal of Experimental Medicine. 215(6). 1555–1569. 118 indexed citations

13.

Lu, Yong, Qiang Wang, Gang Xue, et al.. (2018). Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors. Cancer Cell. 33(6). 1048–1060.e7. 121 indexed citations

14.

Wang, Qiang, Yong Lu, Yanfang Jiang, et al.. (2017). Therapeutic effects of CSF1R-blocking antibodies in multiple myeloma. Leukemia. 32(1). 176–183. 68 indexed citations

15.

Zhao, Hongling, Frederick Bauzon, Enguang Bi, et al.. (2015). Substituting Threonine 187 with Alanine in p27Kip1 Prevents Pituitary Tumorigenesis by Two-Hit Loss of Rb1 and Enhances Humoral Immunity in Old Age. Journal of Biological Chemistry. 290(9). 5797–5809. 11 indexed citations

16.

Peled, Jonathan U., J. Jessica Yu, Venkatesh Jeganathan, et al.. (2010). Requirement for cyclin D3 in germinal center formation and function. Cell Research. 20(6). 631–646. 46 indexed citations

17.

Bi, Enguang, Xiaodong Wu, Yuan Wang, et al.. (2009). Novel sinomenine derivative 1032 improves immune suppression in experimental autoimmune encephalomyelitis. Biochemical and Biophysical Research Communications. 391(1). 1093–1098. 19 indexed citations

18.

Bi, Enguang, Chunjian Huang, Yu Hu, et al.. (2009). Novel function of perforin in negatively regulating CD4+ T cell activation by affecting calcium signaling. Cell Research. 19(7). 816–827. 2 indexed citations

19.

Shi, Mude, Weiwen Deng, Enguang Bi, et al.. (2008). TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation. Nature Immunology. 9(4). 369–377. 216 indexed citations

20.

Huang, Chunjian, Enguang Bi, Yu Hu, et al.. (2006). A Novel NF-κB Binding Site Controls Human Granzyme B Gene Transcription. The Journal of Immunology. 176(7). 4173–4181. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact